Breaking News

GTP Bioways Invests $14M in Biopharma Production Capabilities in France

Strengthens position as a CDMO in Europe by opening two new biopharmaceutical production units at Toulouse site.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GTP Bioways, a contract development and manufacturing organization(CDMO) specializing in the production of biotherapies and nanotherapies, is investing $14 million into two new biopharmaceutical production lines at its site in Toulouse, France.   The first line will be dedicated to production using microbial systems (bacteria and yeast). With a capacity of 300L, it will be operational in the first quarter of 2023; this will enable GTP Bioways to respond to a rapidly growing market.   GTP Bioways...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters